These effects were accompanied by a potent activation of both CD4+ and CD8+ T cells responses as measured by IFNγ and IL-2 production, their infiltration in the tumor, and a reshaping of the immune tumor microenvironment that included reduction of Treg numbers and less IL-10 and TGF-β production. This evidence concerns the gene TGFB1 and neoplasm.